{"id":"W2064192118","doi":"10.3747/co.v16i2.301","title":"Concomitant Renal Cell Carcinoma and Chronic Myelogenous Leukemia: Use of a Targeted Approach","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; Sorafenib; Imatinib; Chronic myelogenous leukemia; Nilotinib; Dasatinib; Renal cell carcinoma; Tyrosine-kinase inhibitor; Concomitant; Tyrosine kinase; Oncology; Bevacizumab; Targeted therapy; Temsirolimus; Internal medicine; Leukemia; Cancer; Chemotherapy; Myeloid leukemia; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001778506,0.0003875814,0.0005112828,0.0005202217,0.0006496787,0.000617622,0.0003532432,0.001300178,0.002358317],"category_scores_gemma":[0.0006024718,0.0001681569,0.0004562332,0.0003812132,0.0006062248,0.0008212693,0.0006399329,0.0008024525,0.0006294847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000659344,"about_ca_system_score_gemma":0.0008967889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001105723,"about_ca_topic_score_gemma":0.002584533,"domain_scores_codex":[0.9998124,0.00002924062,0.00002219313,0.00004341924,0.00003328802,0.00005957059],"domain_scores_gemma":[0.9997826,0.00005797156,0.00005372005,0.00002488233,0.0000144293,0.0000663442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0005745377,0.0004018845,0.05006646,0.0003824436,0.00008159042,0.7745763,0.0001693084,0.0004941237,0.03004629,0.004531325,0.001592452,0.1370833],"study_design_scores_gemma":[0.00005108574,0.0002811415,0.01030594,0.00004683748,0.00006140545,0.9753331,0.00007393552,0.0005367524,0.003881257,0.0007577938,0.008656906,0.00001381339],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8426628,0.06770615,0.0148166,0.01303899,0.0004643697,0.0002868493,0.0001961728,0.0003149916,0.06051319],"genre_scores_gemma":[0.9747378,0.01378553,0.005548451,0.001833678,0.001012648,0.00003497992,0.00007633908,0.00001802664,0.002952588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002358317,"threshold_uncertainty_score":0.00788933,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07053278544921589,"score_gpt":0.321000402360912,"score_spread":0.2504676169116962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}